WorksheetsPBT Online Exam
Total questions: 20
Worksheet time: 3600secs
________ is an unpleasant sensory and emotional experience associated with actual or potential tissue damage or described in terms of such damage” (IASP, 1979)
PAIN
NEUROPATHIC PAIN
NOCICEPTIVE PAIN
Pain initiated or caused by a primary lesion or dysfunction in the nervous system
PAIN
NEUROPATHIC PAIN
NOCICEPTIVE PAIN
____________ is an example of peripheral neuropathic pain.
POST HERPETIC NEURALGIA
SPINAL CORD INJURY
CENTRAL POST STROKE PAIN
Pregabalin reduces calcium influx at presynaptic terminals in hyperexcited neurons.
TRUE
FALSE
What is the recommended starting dose of Pregabalin (Gabi) 75 mg?
OD
BID
TID
What are the most common adverse events of Gabi in diabetic Neuropathy?
a. Dizziness
b. Somnolence
c. A&B
d. None of the choices
What are the available preparations (SKUs) of Pregabalin (Gabi)?
50 mg and 75mg
75mg and 150 mg
150mg and 300 mg
What is the innovator brand and company of Pregabalin?
Funxion, Unilab
Nervagest, Natrapharm
Lyrica, Pfizer
What is the List price of Gabi 75 mg?
34.00
35.00
36.00
What is the priority of Gabi in PBT?
P1
P2
P3
What is the composition of Aclasta?
Amoxicillin 500mg
Sildenafil 50mg
Denusomab
Zoledronic Acid
What is the drug classification of Aclasta?
Anti – Diuretic
Antibiotic
Bisphosphonate or n-BPs or Nitrogen-containing bisphosphonate
Anti- epileptic
What is the formulation of Aclasta?
5mg/100mL Solution for Intravenous Infusion
4mg/100mL Solution for Intravenous Infusion
10mg/100mL Solution for Intravenous Infusion
15mg/100mL Solution for Intravenous Infusion
Mode of Action of Aclasta.
It inhibits osteoclast activity, increasing resorption and turnover thereby leading to increased bone mass.
It inhibits osteoclast activity, reduces resorption and turnover thereby leading to decrease bone mass.
It inhibits osteoclast activity, reduces resorption and turnover thereby leading to increased bone mass.
It inhibits osteoclast activity, reduces resorption and turnover thereby leading to increased bone density.
What is the indication of Aclasta?
Prevention of post-menopausal osteoporosis
Treatment of osteoporosis
Treatment of post-menopausal osteoporosis
Treatment and prevention of post-menopausal osteoporosis & glucocorticoid-induced osteoporosis.
What is the dosage of Aclasta?
5mg Once a Month via IV Infusion
5mg twice a Year via IV Infusion
5mg Once a Year via IV Infusion
5mg Once a Year via IM
What is the packaging of Aclasta?
Infusion solution of 5mg/100 mL per Vial
Infusion solution of 4mg/100 mL per Vial
Infusion solution of 5mg/50 mL per Vial
Infusion solution of 5mg/10 mL per Vial
What is a systemic skeletal-disease characterized by low bone density and micro architectural deterioration of bone tissue with consequent increase in bone fragility?
Menopause
Andropause
Osteoporosis
Paget’s disease
What are the side effects of Aclasta?
Headache
Pain in Extremities
Flu-like symptoms
All options are correct
What are the contraindications of Aclasta?
Hypocalcemia
Pt w/ Creatinine clearance of >35 mL/min
Pregnancy and lactation
All options are correct.
